Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh · Delayed Price · Currency is BDT 217.60
+0.60 (0.28%)
At close: Sep 3, 2026
DSE:SQURPHARMA Market Cap
DSE:SQURPHARMA has a market cap or net worth of 192.89 billion as of September 4, 2026. Its market cap has decreased by -2.86% in one year.
Market Cap
192.89B
Enterprise Value
120.68B
Revenue
83.53B
Ranking
n/a
PE Ratio
7.46
Stock Price
217.60
ChartMarket Cap Chart
Since April 18, 2002, DSE:SQURPHARMA's market cap has increased from 3.10B to 192.89B, an increase of 6,117.31%. That is a compound annual growth rate of 18.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 192.89B | 9.57% |
| Dec 30, 2025 | 176.05B | -8.77% |
| Dec 30, 2024 | 192.98B | 3.52% |
| Dec 28, 2023 | 186.42B | 0.24% |
| Dec 29, 2022 | 185.98B | -2.10% |
| Dec 30, 2021 | 189.97B | -2.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Renata | 53.15B |
| Unilever Consumer Care | 38.52B |
| Beacon Pharmaceuticals | 24.62B |
| The ACME Laboratories | 16.74B |
| Asiatic Laboratories | 13.45B |
| The IBN SINA Pharmaceutical Industry | 9.76B |
| Navana Pharmaceuticals | 7.13B |
| Orion Pharma | 6.18B |